-
1
-
-
84861417701
-
Non-alcoholic fatty liver disease: A new and important cardiovascular risk factor?
-
Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J. 2012;33:1190-1200. doi: 10.1093/eurheartj/ehr453.
-
(2012)
Eur Heart J.
, vol.33
, pp. 1190-1200
-
-
Bhatia, L.S.1
Curzen, N.P.2
Calder, P.C.3
Byrne, C.D.4
-
2
-
-
10644220306
-
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
-
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-1395. doi: 10.1002/hep.20466.
-
(2004)
Hepatology
, vol.40
, pp. 1387-1395
-
-
Browning, J.D.1
Szczepaniak, L.S.2
Dobbins, R.3
Nuremberg, P.4
Horton, J.D.5
Cohen, J.C.6
Grundy, S.M.7
Hobbs, H.H.8
-
3
-
-
20144389650
-
Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease
-
Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Fiorello S, Cavallo MG, Zalunardo B, Lirussi F, Alessandri C, Violi F. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2005;90:1578-1582. doi: 10.1210/jc.2004-1024.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 1578-1582
-
-
Angelico, F.1
Del Ben, M.2
Conti, R.3
Francioso, S.4
Feole, K.5
Fiorello, S.6
Cavallo, M.G.7
Zalunardo, B.8
Lirussi, F.9
Alessandri, C.10
Violi, F.11
-
4
-
-
84863592684
-
Body fat distribution and risk of cardiovascular disease: An update
-
Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126:1301-1313. doi: 10.1161/ CIRCULATIONAHA.111.067264.
-
(2012)
Circulation
, vol.126
, pp. 1301-1313
-
-
Després, J.P.1
-
5
-
-
55949119360
-
Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus
-
Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 2008;52:1793-1799. doi: 10.1016/j.jacc.2008.07.062.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 1793-1799
-
-
Rijzewijk, L.J.1
Van Der Meer, R.W.2
Smit, J.W.3
Diamant, M.4
Bax, J.J.5
Hammer, S.6
Romijn, J.A.7
De Roos, A.8
Lamb, H.J.9
-
6
-
-
84858726310
-
Left ventricular function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve
-
Korosoglou G, Humpert P, Ahrens J, Oikonomou D, Osman NF, Gitsioudis G, Buss SJ, Steen H, Schnackenburg B, Bierhaus A, Nawroth PP, Katus HA. Left ventricular function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve. J Magn Res Imag. 2012;35:804-811.
-
(2012)
J Magn Res Imag
, vol.35
, pp. 804-811
-
-
Korosoglou, G.1
Humpert, P.2
Ahrens, J.3
Oikonomou, D.4
Osman, N.F.5
Gitsioudis, G.6
Buss, S.J.7
Steen, H.8
Schnackenburg, B.9
Bierhaus, A.10
Nawroth, P.P.11
Katus, H.A.12
-
7
-
-
77957954467
-
Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease
-
Fotbolcu H, Yakar T, Duman D, Karaahmet T, Tigen K, Cevik C, Kurtoglu U, Dindar I. Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol J. 2010;17:457-463.
-
(2010)
Cardiol J.
, vol.17
, pp. 457-463
-
-
Fotbolcu, H.1
Yakar, T.2
Duman, D.3
Karaahmet, T.4
Tigen, K.5
Cevik, C.6
Kurtoglu, U.7
Dindar, I.8
-
8
-
-
84859048319
-
Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes
-
Bonapace S, Perseghin G, Molon G, Canali G, Bertolini L, Zoppini G, Barbieri E, Targher G. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care. 2012;35:389-395. doi: 10.2337/dc11-1820.
-
(2012)
Diabetes Care
, vol.35
, pp. 389-395
-
-
Bonapace, S.1
Perseghin, G.2
Molon, G.3
Canali, G.4
Bertolini, L.5
Zoppini, G.6
Barbieri, E.7
Targher, G.8
-
9
-
-
33745856570
-
Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes
-
Lautamäki R, Borra R, Iozzo P, Komu M, Lehtimäki T, Salmi M, Jalkanen S, Airaksinen KE, Knuuti J, Parkkola R, Nuutila P. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab. 2006;291:E282-E290. doi: 10.1152/ajpendo.00604.2005.
-
(2006)
Am J Physiol Endocrinol Metab
, vol.291
, pp. E282-E290
-
-
Lautamäki, R.1
Borra, R.2
Iozzo, P.3
Komu, M.4
Lehtimäki, T.5
Salmi, M.6
Jalkanen, S.7
Airaksinen, K.E.8
Knuuti, J.9
Parkkola, R.10
Nuutila, P.11
-
10
-
-
77955060310
-
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes
-
Rijzewijk LJ, Jonker JT, van der Meer RW, Lubberink M, de Jong HW, Romijn JA, Bax JJ, de Roos A, Heine RJ, Twisk JW, Windhorst AD, Lammertsma AA, Smit JW, Diamant M, Lamb HJ. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. J Am Coll Cardiol. 2010;56:225-233. doi: 10.1016/j.jacc.2010.02.049.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 225-233
-
-
Rijzewijk, L.J.1
Jonker, J.T.2
Van Der Meer, R.W.3
Lubberink, M.4
De Jong, H.W.5
Romijn, J.A.6
Bax, J.J.7
De Roos, A.8
Heine, R.J.9
Twisk, J.W.10
Windhorst, A.D.11
Lammertsma, A.A.12
Smit, J.W.13
Diamant, M.14
Lamb, H.J.15
-
11
-
-
38649091680
-
Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver
-
Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Ntali G, Ragogna F, Canu T, Scifo P, Del Maschio A, Luzi L. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology. 2008;47:51-58. doi: 10.1002/hep.21983.
-
(2008)
Hepatology
, vol.47
, pp. 51-58
-
-
Perseghin, G.1
Lattuada, G.2
De Cobelli, F.3
Esposito, A.4
Belloni, E.5
Ntali, G.6
Ragogna, F.7
Canu, T.8
Scifo, P.9
Del Maschio, A.10
Luzi, L.11
-
12
-
-
84878630492
-
Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease
-
Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, Taylor R, Day CP, Trenell MI. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. J Hepatol. 2013;58:757-762. doi: 10.1016/j.jhep.2012.11.015.
-
(2013)
J Hepatol
, vol.58
, pp. 757-762
-
-
Hallsworth, K.1
Hollingsworth, K.G.2
Thoma, C.3
Jakovljevic, D.4
Macgowan, G.A.5
Anstee, Q.M.6
Taylor, R.7
Day, C.P.8
Trenell, M.I.9
-
13
-
-
84887340400
-
Cardiac steatosis and left ventricular function in men with metabolic syndrome
-
Nyman K, Granér M, Pentikäinen MO, Lundbom J, Hakkarainen A, Sirén R, Nieminen MS, Taskinen MR, Lundbom N, Lauerma K. Cardiac steatosis and left ventricular function in men with metabolic syndrome. J Cardiovasc Magn. 2013;15:103.
-
(2013)
J Cardiovasc Magn
, vol.15
, pp. 103
-
-
Nyman, K.1
Granér, M.2
Pentikäinen, M.O.3
Lundbom, J.4
Hakkarainen, A.5
Sirén, R.6
Nieminen, M.S.7
Taskinen, M.R.8
Lundbom, N.9
Lauerma, K.10
-
14
-
-
70350245011
-
Harmonizing the metabolic syndrome
-
International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
-
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645. doi: 10.1161/ CIRCULATIONAHA.109.192644.
-
(2009)
Circulation
, vol.120
, pp. 1640-1645
-
-
Alberti, K.G.1
Eckel, R.H.2
Grundy, S.M.3
Zimmet, P.Z.4
Cleeman, J.I.5
Donato, K.A.6
Fruchart, J.C.7
James, W.P.8
Loria, C.M.9
Smith, S.C.10
-
15
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
-
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
-
(1972)
Clin Chem
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
17
-
-
84874868379
-
Cardiac steatosis associates with visceral obesity in nondiabetic obese men
-
Granér M, Siren R, Nyman K, Lundbom J, Hakkarainen A, Pentikäinen MO, Lauerma K, Lundbom N, Adiels M, Nieminen MS, Taskinen MR. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. J Clin Endocrinol Metab. 2013;98:1189-1197. doi: 10.1210/ jc.2012-3190.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. 1189-1197
-
-
Granér, M.1
Siren, R.2
Nyman, K.3
Lundbom, J.4
Hakkarainen, A.5
Pentikäinen, M.O.6
Lauerma, K.7
Lundbom, N.8
Adiels, M.9
Nieminen, M.S.10
Taskinen, M.R.11
-
18
-
-
84866073021
-
The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk
-
Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55:2622-2630. doi: 10.1007/s00125-012-2639-5.
-
(2012)
Diabetologia
, vol.55
, pp. 2622-2630
-
-
Kaess, B.M.1
Pedley, A.2
Massaro, J.M.3
Murabito, J.4
Hoffmann, U.5
Fox, C.S.6
-
19
-
-
79959779173
-
Myocardial, perivascular, and epicardial fat
-
Iozzo P. Myocardial, perivascular, and epicardial fat. Diab Care. 2011;34:371-379.
-
(2011)
Diab Care
, vol.34
, pp. 371-379
-
-
Iozzo, P.1
-
20
-
-
78649658552
-
Chylomicron- and VLDLderived lipids enter the heart through different pathways: In vivo evidence for receptor- and non-receptor-mediated fatty acid uptake
-
Bharadwaj KG, Hiyama Y, Hu Y, Huggins LA, Ramakrishnan R, Abumrad NA, Shulman GI, Blaner WS, Goldberg IJ. Chylomicron- and VLDLderived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake. J Biol Chem. 2010;285:37976-37986. doi: 10.1074/jbc.M110.174458.
-
(2010)
J Biol Chem
, vol.285
, pp. 37976-37986
-
-
Bharadwaj, K.G.1
Hiyama, Y.2
Hu, Y.3
Huggins, L.A.4
Ramakrishnan, R.5
Abumrad, N.A.6
Shulman, G.I.7
Blaner, W.S.8
Goldberg, I.J.9
-
21
-
-
79959923796
-
The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction
-
Perman JC, Boström P, Lindbom M, Lidberg U, StÅhlman M, Hägg D, Lindskog H, Scharin Täng M, Omerovic E, Mattsson Hultén L, Jeppsson A, Petursson P, Herlitz J, Olivecrona G, Strickland DK, Ekroos K, Olofsson SO, Borén J. The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. J Clin Invest. 2011;121:2625-2640. doi: 10.1172/JCI43068.
-
(2011)
J Clin Invest
, vol.121
, pp. 2625-2640
-
-
Perman, J.C.1
Boström, P.2
Lindbom, M.3
Lidberg, U.4
Ståhlman, M.5
Hägg, D.6
Lindskog, H.7
Scharin Täng, M.8
Omerovic, E.9
Mattsson Hultén, L.10
Jeppsson, A.11
Petursson, P.12
Herlitz, J.13
Olivecrona, G.14
Strickland, D.K.15
Ekroos, K.16
Olofsson, S.O.17
Borén, J.18
-
22
-
-
84876557451
-
Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy
-
Pulinilkunnil T, Kienesberger PC, Nagendran J, Waller TJ, Young ME, Kershaw EE, Korbutt G, Haemmerle G, Zechner R, Dyck JR. Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy. Diabetes. 2013;62:1464-1477. doi: 10.2337/db12-0927.
-
(2013)
Diabetes
, vol.62
, pp. 1464-1477
-
-
Pulinilkunnil, T.1
Kienesberger, P.C.2
Nagendran, J.3
Waller, T.J.4
Young, M.E.5
Kershaw, E.E.6
Korbutt, G.7
Haemmerle, G.8
Zechner, R.9
Dyck, J.R.10
-
23
-
-
70350349875
-
Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome
-
Marfella R, Di Filippo C, Portoghese M, Barbieri M, Ferraraccio F, Siniscalchi M, Cacciapuoti F, Rossi F, D'Amico M, Paolisso G. Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. J Lipid Res. 2009;50:2314-2323. doi: 10.1194/jlr.P900032-JLR200.
-
(2009)
J Lipid Res
, vol.50
, pp. 2314-2323
-
-
Marfella, R.1
Di Filippo, C.2
Portoghese, M.3
Barbieri, M.4
Ferraraccio, F.5
Siniscalchi, M.6
Cacciapuoti, F.7
Rossi, F.8
D'Amico, M.9
Paolisso, G.10
-
24
-
-
84868008035
-
Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans
-
Labbé SM, Grenier-Larouche T, Noll C, Phoenix S, Guérin B, Turcotte EE, Carpentier AC. Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans. Diabetes. 2012;61:2701-2710. doi: 10.2337/db11-1805.
-
(2012)
Diabetes
, vol.61
, pp. 2701-2710
-
-
Labbé, S.M.1
Grenier-Larouche, T.2
Noll, C.3
Phoenix, S.4
Guérin, B.5
Turcotte, E.E.6
Carpentier, A.C.7
-
25
-
-
84861038555
-
The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial
-
McGavock J, Szczepaniak LS, Ayers CR, Abdullah SM, See R, Gore MO, Drazner MH, de Lemos JA, McGuire DK. The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial. Diab Vasc Dis Res. 2011;9:131-137.
-
(2011)
Diab Vasc Dis Res
, vol.9
, pp. 131-137
-
-
McGavock, J.1
Szczepaniak, L.S.2
Ayers, C.R.3
Abdullah, S.M.4
See, R.5
Gore, M.O.6
Drazner, M.H.7
De Lemos, J.A.8
McGuire, D.K.9
-
26
-
-
78650683294
-
Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus
-
Ng A, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Hooi Ewe S, Siebelink HM, Smit JW, Diamant M, Romijn JA, de Roos A, Leung DY, Lamb HJ, Bax JJ. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation. 2010;122:2538-2544.
-
(2010)
Circulation
, vol.122
, pp. 2538-2544
-
-
Ng, A.1
Delgado, V.2
Bertini, M.3
Van Der Meer, R.W.4
Rijzewijk, L.J.5
Hooi Ewe, S.6
Siebelink, H.M.7
Smit, J.W.8
Diamant, M.9
Romijn, J.A.10
De Roos, A.11
Leung, D.Y.12
Lamb, H.J.13
Bax, J.J.14
-
27
-
-
0038488294
-
Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with wellcontrolled type 2 diabetes mellitus
-
Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, de Roos A, Radder JK. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with wellcontrolled type 2 diabetes mellitus. J Am Coll Cardiol. 2003;42:328-335.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 328-335
-
-
Diamant, M.1
Lamb, H.J.2
Groeneveld, Y.3
Endert, E.L.4
Smit, J.W.5
Bax, J.J.6
Romijn, J.A.7
De Roos, A.8
Radder, J.K.9
-
28
-
-
84858283635
-
Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: Relationship to metabolic profile, cardiac function and visceral fat
-
Gaborit B, Kober F, Jacquier A, Moro PJ, Cuisset T, Boullu S, Dadoun F, Alessi MC, Morange P, Clément K, Bernard M, Dutour A. Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat. Int J Obes. 2012;36.422-430.
-
(2012)
Int J Obes
, vol.36
, pp. 422-430
-
-
Gaborit, B.1
Kober, F.2
Jacquier, A.3
Moro, P.J.4
Cuisset, T.5
Boullu, S.6
Dadoun, F.7
Alessi, M.C.8
Morange, P.9
Clément, K.10
Bernard, M.11
Dutour, A.12
-
29
-
-
80052685297
-
Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin- resistant obese women
-
Utz W, Engeli S, Haufe S, Kast P, Hermsdorf M, Wiesner S, Pofahl M, Traber J, Luft FC, Boschmann M, Schulz-Menger J, Jordan J. Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin- resistant obese women. Heart. 2011;97:1585-1589. doi: 10.1136/ hrt.2011.224451.
-
(2011)
Heart
, vol.97
, pp. 1585-1589
-
-
Utz, W.1
Engeli, S.2
Haufe, S.3
Kast, P.4
Hermsdorf, M.5
Wiesner, S.6
Pofahl, M.7
Traber, J.8
Luft, F.C.9
Boschmann, M.10
Schulz-Menger, J.11
Jordan, J.12
-
30
-
-
79960215555
-
Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period
-
Hamabe A, Uto H, Imamura Y, Kusano K, Mawatari S, Kumagai K, Kure T, Tamai T, Moriuchi A, Sakiyama T, Oketani M, Ido A, Tsubouchi H. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol. 2011;46:769-778. doi: 10.1007/ s00535-011-0376-z.
-
(2011)
J Gastroenterol
, vol.46
, pp. 769-778
-
-
Hamabe, A.1
Uto, H.2
Imamura, Y.3
Kusano, K.4
Mawatari, S.5
Kumagai, K.6
Kure, T.7
Tamai, T.8
Moriuchi, A.9
Sakiyama, T.10
Oketani, M.11
Ido, A.12
Tsubouchi, H.13
-
31
-
-
74249109801
-
Synergistic effect of fatty liver and smoking on metabolic syndrome
-
Chiang PH, Chang TY, Chen JD. Synergistic effect of fatty liver and smoking on metabolic syndrome. World J Gastroenterol. 2009;15:5334-5339.
-
(2009)
World J Gastroenterol
, vol.15
, pp. 5334-5339
-
-
Chiang, P.H.1
Chang, T.Y.2
Chen, J.D.3
|